Search research articles
Contact Us
Filters
Showing results (21-30 of 56) with videos related to
Page
of 6
Sort By:
Frontiers in Immunology
|
March 30, 2023
Allergen sensitization stratifies IL-31 production by memory T cells in atopic dermatitis patients
Lídia Sans-de San Nicolàs, Ignasi Figueras-Nart, Irene García-Jiménez, et al.
Lancet (London, England)
|
July 21, 2024
Efficacy and safety of delgocitinib cream in adults with moderate to severe chronic hand eczema (DELTA 1 and DELTA 2): results from multicentre, randomised, controlled, double-blind, phase 3 trials
Robert Bissonnette, Richard B Warren, Andreas Pinter, et al.
The British Journal of Dermatology
|
March 30, 2023
Efficacy and safety of lebrikizumab in moderate-to-severe atopic dermatitis: 52-week results of two randomized double-blinded placebo-controlled phase III trials
Andrew Blauvelt, Jacob P Thyssen, Emma Guttman-Yassky, et al.
International Journal of Dermatology
|
June 2, 2025
Clinical Characteristics, Diagnostic Approaches, Therapeutic Management, and Associated Comorbidities of Prurigo Nodularis (Chronic Nodular Prurigo): An Observational Study in Clinical Practice in Spain
José Carlos Armario-Hita, Jose Juan Pereyra-Rodriguez, Francisco Javier de Ortiz de Frutos, et al.
Journal of the American Academy of Dermatology
|
March 13, 2025
Long-term safety and efficacy of delgocitinib cream for up to 52 weeks in adults with Chronic Hand Eczema: Results of the phase 3 open-label extension DELTA 3 trial following the DELTA 1 and 2 trials
Melinda Gooderham, Sonja Molin, Robert Bissonnette, et al.
Dermatology and Therapy
|
April 21, 2026
Real-World Use of Baricitinib in Patients with Atopic Dermatitis in Spain: DAMA-S Study, A Retrospective Chart Review
Enrique Gómez de la Fuente, Enrique Herrera, Iñigo Martinez-Espronceda Esquerdo, et al.
Journal of the American Academy of Dermatology
|
August 19, 2018
Humanistic burden of chronic pruritus in patients with inflammatory dermatoses: Results of the European Academy of Dermatology and Venereology Network on Assessment of Severity and Burden of Pruritus (PruNet) cross-sectional trial
Sabine Steinke, Claudia Zeidler, Claudia Riepe, et al.
International Journal of Dermatology
|
October 19, 2024
Treatment of atopic dermatitis with abrocitinib in real practice in Spain: efficacy and safety results from a 24-week multicenter study
Jose Carlos Armario-Hita, Jose Juan Pereyra-Rodriguez, Alicia González-Quesada, et al.
Clinical and Experimental Dermatology
|
April 25, 2023
Treatment of severe atopic dermatitis with tralokinumab in clinical practice: short-term effectiveness and safety results
José-Juan Pereyra-Rodríguez, Pedro Herranz, Ricardo Ruiz-Villaverde, et al.
Dermatitis : Contact, Atopic, Occupational, Drug
|
March 31, 2023
Patch Testing in Patients With Severe Atopic Dermatitis Treated With Dupilumab: A Multicentric Approach in Spain
Alexandre Docampo-Simón, María J Sánchez-Pujol, Maria A Pastor-Nieto, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 56) with videos related to
Sort By:
Page
of 6
Frontiers in Immunology
|
March 30, 2023
Allergen sensitization stratifies IL-31 production by memory T cells in atopic dermatitis patients
Lídia Sans-de San Nicolàs, Ignasi Figueras-Nart, Irene García-Jiménez, et al.
Lancet (London, England)
|
July 21, 2024
Efficacy and safety of delgocitinib cream in adults with moderate to severe chronic hand eczema (DELTA 1 and DELTA 2): results from multicentre, randomised, controlled, double-blind, phase 3 trials
Robert Bissonnette, Richard B Warren, Andreas Pinter, et al.
The British Journal of Dermatology
|
March 30, 2023
Efficacy and safety of lebrikizumab in moderate-to-severe atopic dermatitis: 52-week results of two randomized double-blinded placebo-controlled phase III trials
Andrew Blauvelt, Jacob P Thyssen, Emma Guttman-Yassky, et al.
International Journal of Dermatology
|
June 2, 2025
Clinical Characteristics, Diagnostic Approaches, Therapeutic Management, and Associated Comorbidities of Prurigo Nodularis (Chronic Nodular Prurigo): An Observational Study in Clinical Practice in Spain
José Carlos Armario-Hita, Jose Juan Pereyra-Rodriguez, Francisco Javier de Ortiz de Frutos, et al.
Journal of the American Academy of Dermatology
|
March 13, 2025
Long-term safety and efficacy of delgocitinib cream for up to 52 weeks in adults with Chronic Hand Eczema: Results of the phase 3 open-label extension DELTA 3 trial following the DELTA 1 and 2 trials
Melinda Gooderham, Sonja Molin, Robert Bissonnette, et al.
Dermatology and Therapy
|
April 21, 2026
Real-World Use of Baricitinib in Patients with Atopic Dermatitis in Spain: DAMA-S Study, A Retrospective Chart Review
Enrique Gómez de la Fuente, Enrique Herrera, Iñigo Martinez-Espronceda Esquerdo, et al.
Journal of the American Academy of Dermatology
|
August 19, 2018
Humanistic burden of chronic pruritus in patients with inflammatory dermatoses: Results of the European Academy of Dermatology and Venereology Network on Assessment of Severity and Burden of Pruritus (PruNet) cross-sectional trial
Sabine Steinke, Claudia Zeidler, Claudia Riepe, et al.
International Journal of Dermatology
|
October 19, 2024
Treatment of atopic dermatitis with abrocitinib in real practice in Spain: efficacy and safety results from a 24-week multicenter study
Jose Carlos Armario-Hita, Jose Juan Pereyra-Rodriguez, Alicia González-Quesada, et al.
Clinical and Experimental Dermatology
|
April 25, 2023
Treatment of severe atopic dermatitis with tralokinumab in clinical practice: short-term effectiveness and safety results
José-Juan Pereyra-Rodríguez, Pedro Herranz, Ricardo Ruiz-Villaverde, et al.
Dermatitis : Contact, Atopic, Occupational, Drug
|
March 31, 2023
Patch Testing in Patients With Severe Atopic Dermatitis Treated With Dupilumab: A Multicentric Approach in Spain
Alexandre Docampo-Simón, María J Sánchez-Pujol, Maria A Pastor-Nieto, et al.
Page
of 6